Does renal cell carcinoma (RCC) metastasize to the leptomeninges?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Renal cell carcinoma (RCC) can spread to the leptomeninges, though this is relatively rare, as reported in a case series and literature review published in 2019 1. Leptomeningeal metastasis occurs in approximately 1-2% of RCC cases, typically presenting as a late manifestation of advanced disease. When RCC spreads to the leptomeninges, patients may experience symptoms such as:

  • Headaches
  • Mental status changes
  • Cranial nerve deficits
  • Back pain
  • Radicular symptoms Diagnosis typically requires MRI with gadolinium enhancement of the brain and spine, along with cerebrospinal fluid analysis looking for malignant cells. Treatment options include:
  • Systemic therapy (targeted agents like tyrosine kinase inhibitors or immunotherapy)
  • Intrathecal chemotherapy
  • Radiation therapy to symptomatic sites The prognosis for RCC with leptomeningeal involvement is generally poor, with median survival typically measured in months, as discussed in a study on leptomeningeal carcinomatosis published in 1999 2. Early recognition of neurological symptoms in RCC patients is important as prompt diagnosis and treatment may help manage symptoms and potentially improve quality of life, even if it doesn't significantly extend survival. According to a study on radiotherapy for brain metastases from renal cell cancer published in 2010 3, addition of whole-brain radiotherapy to stereotactic radiosurgery offers better intracerebral control and should be considered for RCC patients with one to three brain metastases. Additionally, a case report published in 2007 4 demonstrated that precise high-dose radiation in the form of stereotactic radiosurgery can cause significant tumor cell death in radiation-resistant brain metastases from RCC. The exact mechanism of how cancer cells reach the leptomeninges is not fully understood, but it is thought to occur through various routes, including hematogenous spread, direct extension from pre-existing lesions, or through perineural spaces, as discussed in a study published in 1983 5. However, the most recent and highest quality study on this topic is the 2019 case series and literature review 1, which provides the most relevant and up-to-date information on the spread of RCC to the leptomeninges.

Related Questions

What is the recommended imaging for diagnosing carcinomatosis meningea?
What is the management approach for leptomeningeal enhancement?
What is leptomeningeal carcinomatosis (LC), a condition where cancer cells spread to the leptomeninges?
What are the treatment options for Primary Meningeal Cancer (PMC) in the brain?
What symptoms does carcinomatosis meningea cause in a patient?
What are the symptoms of Leishmaniasis (Leishmania infection)?
What is the optimal management for a patient with acute arterial stroke and erythrocytosis, awaiting JAK2 (Janus kinase 2) results, with low erythropoietin levels, currently on aspirin, regarding the choice between Direct Oral Anticoagulant (DOAC) and Low Molecular Weight Heparin (LMWH), and between hydroxyurea and phlebotomy (venesections) for reducing erythrocyte burden?
What is the comparison between Lactated Ringer's (LR) solution and 0.9% Sodium Chloride (Normal Saline) solution for use in Emergency Medical Services (EMS)?
Can tirzepatide (a dual GIP and GLP-1 receptor agonist) be taken with a history of cerebrovascular accident (CVA), hypertension, and diverticulitis?
What is the significance of a normal magnesium level in a 40-year-old female patient with anxiety and panic attacks, currently on Sertraline (selective serotonin reuptake inhibitor), who has shown improvement in symptoms, including resolution of palpitations?
Can tirzepatide be taken with a history of cerebrovascular accident (CVA), hypertension, diverticulitis, hypothyroidism, and hypercholesterolemia, while on metoprolol, rosuvastatin (Crestor), aspirin, and natural porcine (NP) thyroid replacement therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.